Moderna (NASDAQ:MRNA) Price Target Lowered to $32.00 at Morgan Stanley
Moderna (NASDAQ:MRNA – Get Free Report) had its price objective cut by analysts at Morgan Stanley from $39.00 to $32.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 30.61% from the stock’s previous close. […]
Moderna (NASDAQ:MRNA – Get Free Report) had its price objective cut by analysts at Morgan Stanley from $39.00 to $32.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 30.61% from the stock’s previous close. […]
